logo
episode-header-image
Nov 2023
54 m

Alzheimer’s Update, Part 2

NEJM Group
About this episode
This episode explores the current state of research on the multiple likely mechanisms of Alzheimer’s disease as well as promising treatments and diagnostics. A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2309944. 
Up next
Dec 2023
Is Xenotransplantation Ready for Prime Time?
This episode examines the need for and promise of xenotransplantation, considering first the plight of patients and then the progress being made by researchers. A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2309946. 
47m 23s
Dec 2023
Covid Update
This episode examines Covid-19 variants that are currently circulating, recommendations for booster shots, and new treatments in the pipeline. A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2311327. 
20m 41s
Jan 2024
Investigating Injustices in the Journal's History
Over its 200-plus years, the Journal has sometimes published articles that have perpetuated injustices against various groups of people. A new Perspective series explores that history and its lessons. A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJ ... Show More
21m 31s
Recommended Episodes
Apr 2024
Dementia News Roundup - Frankly Speaking Ep 378
<p>Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-378'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-378</a></p> <p>Overview: Effective treatmen ... Show More
10m 37s
Apr 2023
Audio long read: Conquering Alzheimer’s — a look at the therapies of the future
Last year, researchers announced that the Alzheimer’s drug lecanemab lowered the amount of amyloid protein plaques associated with the disease in the brains of participants in a clinical trial, and slowed their cognitive decline.Now, researchers are looking to drug combinations, ... Show More
17m 31s
Feb 2024
Unveiling the Bigger Picture of Alzheimer's Disease: From New Disease Mechanisms to Biomarkers
<pre class="syntaxhighlighter-pre" data-syntaxhighlighter-params= "brush: xml; gutter: false; theme: Midnight" data-theme= "Midnight">Do you know all there is to know beyond amyloid and tau in Alzheimer's disease? Credit available for this activity expires: 02/15/25 Earn Credit ... Show More
33m 41s
Sep 2024
The Dual Advantage: Improving Alzheimer Care with Combination Therapy - Frankly Speaking Ep 399
<p>Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-399'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-399</a></p> <p>Overview: In this episode, w ... Show More
10m 17s
Jul 2023
AAN President Elect Testified Before House Subcommittee on New Alzheimer Treatment
Dr. Stacey Clardy talks with Dr. Natalia Rost about her experience speaking before the House of Representatives on the approval of lecanemab for the treatment of early Alzheimer disease. Visit NPUb.org/Podcast for associated article links. This episode was sponsored by the ExTING ... Show More
14m 27s
Dec 2024
156| Updated Diagnosis and Staging Criteria for Alzheimer's Disease – A Conversation with Dr. Cliff Jack and Dr. Kevin Duff
<p class="MsoNormal">This episode is a conversation with Drs. Clifford Jack and Kevin Duff about recent updates to the diagnosis and staging of Alzheimer's disease (AD). We discuss biological versus clinical/pathological approaches to diagnosing AD, analogies between AD and other ... Show More
1h 44m
Jul 2024
Dementia
<p>This episode covers dementia.<br/><br/>Written notes can be found at <a href='https://zerotofinals.com/moremedicine/psychiatry/dementia/'>https://zerotofinals.com/moremedicine/psychiatry/dementia/</a> or in the psychiatry section of the Zero to Finals More Medicine book (due l ... Show More
12m 25s
May 2022
Liana G. Apostolova, MS, MD, FAAN - Accelerating Progress in the Treatment of Alzheimer’s Disease: How Can We Achieve Timely and Accurate Neuropathological Diagnosis and Precision Management of Mild Cognitive Impairment in Early Alzheimer’s Disease?
Go online to PeerView.com/JYU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Alzheimer’s disease (AD) is a devastating, progressive neurodegenerative disorder affecting 10% of people over age 65 and increasing in global prev ... Show More
1h 44m